Support and Resistance Levels
Past performance
About Natco Pharma Ltd Natco Pharma Limited is a research-driven pharmaceutical company that develops, manufactures, and markets Finished Dosage Formulations (FDF) and Active Pharmaceutical Ingredients (APIs). With a focus on niche therapeutic areas and complex products, Natco operates in over 40 countries, including the United States, India, and Europe. The company's API capabilities include multi-step synthesis and high-potency APIs. Natco is also involved in contract manufacturing for other pharmaceutical firms.
Founded in 1981, Natco has expanded its global presence through strategic acquisitions and joint ventures. It has successfully launched several generic drugs, including pioneering generic alternatives for hepatitis C and cancer treatments. In recent years, Natco has focused on expanding its product portfolio across various therapeutic areas, including cardiology, diabetology, and oncology. It also entered the pesticide market with Chlorantraniliprole formulations. As of 2023, Natco has eight international subsidiaries, enhancing its reach and impact in the global pharmaceutical market.